tirzepatide and glp 1 vs Semaglutide | Understanding The Differences Effects of tirzepatide, a dual

Caspase-3 suppression: The "executioner" enzyme of apoptosis was reduced by 42.7%, directly blocking the cell death cascade

Interestingly, GLP-1 receptor agonists, a class of drugs that includes Tirzepatide, have been found to cross the blood-brain barrier, where they may exert protective effects on neurons

doi: 10.1007/S13205-017-0986-0 132 AshcroftFMProksPSmithPAmmlCBokvistKRorsmanP

In STEP 1 [1] , the largest trial with 1,961 participants [1] , patients receiving semaglutide 2.4 mg weekly achieved an average weight loss of 14.9% over 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021)

"The staff are excellent